U.S. Markets closed

This Biotech Is More Than Its Lead Gene Therapies: Here Are 4 Drugs To Note

ALLISON GATLIN
This Biotech Is More Than Its Lead Gene Therapies: Here Are 4 Drugs To Note

An analyst suggested investors look at Sarepta Therapeutics' array of gene therapies on Tuesday after rival Solid Biosciences reported its key gene therapy caused side effects in a patient.